Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$10.03
-0.11-1.08%
Last update: Sep 18, 2:41 PM
Ocular Therapeutix Inc (OCUL) Stock Price, Quote, News & History
OCULNASDAQ
Ocular Therapeutix (OCUL) Stock Price, Quote, News & History | Benzinga
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ocular Therapeutix (OCUL) stock?
You can purchase shares of Ocular Therapeutix (NASDAQ:OCUL) through any online brokerage.
Who are Ocular Therapeutix (OCUL) competitors?
Other companies in Ocular Therapeutix’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
What is the forecast, or price target, for Ocular Therapeutix (OCUL) stock?
Ocular Therapeutix has a consensus price target of $22.73.
What is the current price for Ocular Therapeutix (OCUL)?
The stock price for Ocular Therapeutix (NASDAQ: OCUL) is $10.03 last updated September 18, 2026 at 2:41 PM EDT.
Does Ocular Therapeutix (OCUL) pay a dividend?
There are no upcoming dividends for Ocular Therapeutix.
When is Ocular Therapeutix (NASDAQ:OCUL) reporting earnings?
Ocular Therapeutix does not have any upcoming earnings scheduled.
Is Ocular Therapeutix (OCUL) going to split?
There is no upcoming split for Ocular Therapeutix.
What sector and industry does Ocular Therapeutix (OCUL) operate in?
Ocular Therapeutix is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
